Another question already! I was told I do not qualify for zelboraf because my BRAF gene is "abnormal". Again, that happen to anybody else?
what do you mean 'abnormal'...give us the results...is it braf v600e or k? or wild type?
did you get tested for other mutations like ckit?
what have you tried so far?
don't back up, don't back down
Don't think they meant abnormal.Braf is either positive or negative.Zelboraf will only work on patients who have tested positive.If you are negative it is not a course of treatment.Find another course of treatment.Prayers go with you. Al
"abnormal" is the term they used. Im positive for the gene mutation, but it isn't the same as everybody else's. My onc did his very best at the big symposium last fall to find a center that had run across, but, alas, no one had seen it before.... I will ask again Friday.
I can do all things through Christ who strengthens me.
I have a BRAF mutation, G466E. Maybe that would also be what your doc calls 'abnormal'. It doesn't qualify me for any of the BRAF inhibitors, which all target the V600E or V600K mutations as far as I know.
2 primaries; lung/brain mets in past; paratracheal lymph node currently; participating in Opdivo/Lirilumab trial
I will take that piece of info with me when I see onc. On Friday. Thanks very much!
Meet and talk to others about melanoma in our forums:
See also: History of the MPIP Forum
–CURE OM Forum
Questions to Ask Your Doctor
Email the MRF Nurse
Get matched with a Phone Buddy
View the Melanoma Glossary
Raise awareness and funds to fight melanoma by participating in a Miles for Melanoma 5k walk/run this year!
Find a Miles for Melanoma event near you.
Patient Helpline: (877) 673-6460
1411 K Street, NW Suite 800
Washington, DC 20005
(800) 673-1290 Office
(202) 347-9678 Fax
The Melanoma Research Foundation (MRF) is leading the melanoma community to transform melanoma from one of the deadliest cancers to one of the most treatable through research, education and advocacy.
The Melanoma Research Foundation is a 501(c)(3) non-profit organization.